Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease

Clinical Gastroenterology and Hepatology(2023)10.1016/j.cgh.2023.04.017Source: DataRank Database

Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease is a research paper published in Clinical Gastroenterology and Hepatology (2023). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

24 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 4.24)OA: closedTopics (40)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Tracey G. Simon ORCID,Hannes Hagström ORCID,Paul Lochhead,Björn Roelstraete ORCID,Jonas Söderling ORCID

Live enrichment

PubMed:37121528 OpenAlex:https://openalex.org/W4367319192

National Institutes of Health

Grant: K23 DK122104

Karolinska Institute

Grant: unidentified

unidentified

Karolinska Institutet

Cancerfonden

Center for Innovative Medicine

Irving Medical Center, Columbia University

Vetenskapsrådet

FWCI

4.24

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

closedLicense: Elsevier TDM

publisherhttps://api.elsevier.com/content/article/PII:S1542356523003178?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1542356523003178?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cgh.2023.04.017

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37121528

Fields of Study

Liver Disease Diagnosis and TreatmentHepatitis C virus researchLiver Diseases and Immunity0303 health sciences03 medical and health sciences

MeSH Terms

FibrosisHepatitis, Viral, HumanCarcinoma, HepatocellularHumansLiver CirrhosisLiver NeoplasmsHydroxymethylglutaryl-CoA Reductase InhibitorsHepatitis, AutoimmuneNon-alcoholic Fatty Liver Disease

Keywords

MedicineInternal medicineNonalcoholic fatty liver diseaseLiver diseaseStatinGastroenterologyHazard ratioLiver transplantationCirrhosisHepatitis CViral hepatitisChronic liver diseaseFatty liverDiseaseTransplantationConfidence intervalHepatocellular carcinomafibrosisLiver CirrhosisHepatitis, AutoimmuneCarcinoma, HepatocellularHepatitis, Viral, HumanNon-alcoholic Fatty Liver DiseaseLiver NeoplasmsHumansHydroxymethylglutaryl-CoA Reductase Inhibitors

Sustainable Development Goals

SDG 0: Good health and well-being

Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease

FAIR Checklist

Authors (9)

Funding (7 grants)

Impact

Open Access

Topics